Pharmacy Board of Australia v Chan

Link copied
Case Copied 19 min read
CITATION: Pharmacy Board of Australia v Chan [2013] QCAT 255
PARTIES: Pharmacy Board of Australia
(Applicant)
v
Paul Chan
(Respondent)
APPLICATION NUMBER: OCR005-12
MATTER TYPE: Occupational regulation matters
HEARING DATE: On the papers
HEARD AT: Brisbane
DECISION OF:

Judge Alexander Horneman-Wren SC, Deputy President

Assisted by
Dr Eleanor Milligan
Dr Karin Walduck
Ms Pamela Mathers

DELIVERED ON: 5 March 2013
DELIVERED AT: Brisbane
ORDERS MADE:

1.    Mr Paul Chan's registration be suspended for a period of 6 months, to be wholly suspended for an operational period of 12 months during which time Mr Chan must not engage in any conduct in respect of which he is liable to disciplinary action by the Board or the Tribunal.

2.    The following conditions be imposed on Mr Chan's registration:

a.    Mr Chan must complete a tertiary module on ethical decision making within 12 months of the date of the Tribunal's decision;

b.    For the purpose of condition (a) above, Mr Chan is to nominate a course for the approval of the Board;

c.    Mr Chan is to submit documentary evidence to the Board upon completion of the course;

d.    Mr Chan must participate in a mentoring program for 6 months which includes the following elements:

                  i.    The Mentor is to be a senior registered pharmacist approved by the Board;

                 ii.    Mr Chan must meet the Mentor on a monthly basis for no less than 2 hours;

                iii.    The mentoring relationship will be directed to professional practice processes, currency of knowledge and practice, clinical competence and professional obligations;

                iv.    Mr Chan will authorise the Mentor to provide a report in writing to the Board at the end of each quarter and the end of the period of the mentoring;

e.    Mr Chan is to nominate a Mentor for the approval of the Board within 2 months of the date of the Tribunal's decision;

f.     Mr Chan must bear the costs incurred to comply with these conditions;

g.    Mr Chan must not be the preceptor of any intern pharmacist during the operational period of the suspended suspension.

3.    The review period of the conditions imposed on the Mr Chan's registration is 12 months from the date of the Tribunal's decision.

4.    Mr Chan not be permitted to apply for reinstatement of his unrestricted endorsement to deal with PSE until he has complied with conditions (a) and (d).

5.    Mr Chan pay the Board's costs of and incidental to these proceedings fixed in the sum of $12,000.

6.    Until further order of the Tribunal the publication of any information identifying the persons referred to in the decision as KN, KL, BD and LB is prohibited.

CATCHWORDS:

PROFESSIONS AND TRADES – HEALTH CARE PROFESSIONALS – PHARMACEUTICAL CHEMISTS – DISCIPLINARY PROCEEDINGS – where the Registrant inappropriately dispensed pseudoephedrine – where the Board alleged unprofessional conduct – where the Board alleged professional misconduct – where the Registrant admitted professional misconduct –whether the Tribunal should find the conduct amounted to professional misconduct

PROFESSIONS AND TRADES – HEALTH CARE PROFESSIONALS –…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Pharmacy Board of Australia v Chan and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2013] QCAT 255
Decision Date

CaseChat Overview and Summary

The Pharmacy Board of Australia brought proceedings against Mr Paul Chan, a registered pharmacist, concerning allegations of inappropriate dispensing of pseudoephedrine. The matter was heard by the Health, Professional and Disability Services Tribunal in Australia. The Board alleged that Mr Chan's conduct amounted to both unprofessional conduct and professional misconduct under the Health Practitioner Regulation National Law. Mr Chan admitted to professional misconduct, and the Tribunal was required to determine the appropriate sanction and any additional conditions to be imposed on his registration.

The Tribunal considered the nature of the misconduct, the impact of Mr Chan's actions, and the submissions made by both parties regarding the appropriate sanction. The Board presented evidence of sales and identified certain individuals who did not participate in the proceedings. The Tribunal assessed the submissions and evidence, taking into account the agreed sanction proposed by both parties. The Tribunal found that the conduct amounted to professional misconduct and accepted the agreed sanction of a six-month suspension of Mr Chan's registration, to be wholly suspended for an operational period of 12 months. Additionally, the Tribunal imposed conditions on Mr Chan's registration, including mandatory completion of a tertiary module on ethical decision-making, participation in a mentoring program, and other specified conditions.

The Tribunal's decision included several orders. Mr Chan's registration was suspended for six months, wholly suspended for 12 months, during which he was prohibited from engaging in conduct liable to disciplinary action. Conditions were imposed on his registration, including completing a tertiary module on ethical decision-making, participating in a mentoring program, and bearing the costs associated with these conditions. Mr Chan was also required to pay the Board's costs of the proceedings. Furthermore, the Tribunal made a non-publication order regarding certain individuals named in the decision, prohibiting the publication of information identifying them. Mr Chan was not permitted to apply for reinstatement of his unrestricted endorsement to deal with pseudoephedrine until he complied with the specified conditions.

Orders

Orders of the court

1. Mr Paul Chan's registration be suspended for a period of 6 months, to be wholly suspended for an operational period of 12 months during which time Mr Chan must not engage in any conduct in respect of which he is liable to disciplinary action by the Board or the Tribunal.

2. The following conditions be imposed on Mr Chan's registration:

a. Mr Chan must complete a tertiary module on ethical decision making within 12 months of the date of the Tribunal's decision;

b. For the purpose of condition (a) above, Mr Chan is to nominate a course for the approval of the Board;

c. Mr Chan is to submit documentary evidence to the Board upon completion of the course;

d. Mr Chan must participate in a mentoring program for 6 months which includes the following elements:

i. The Mentor is to be a senior registered pharmacist approved by the Board;

ii. Mr Chan must meet the Mentor on a monthly basis for no less than 2 hours;

iii. The mentoring relationship will be directed to professional practice processes, currency of knowledge and practice, clinical competence and professional obligations;

iv. Mr Chan will authorise the Mentor to provide a report in writing to the Board at the end of each quarter and the end of the period of the mentoring;

e. Mr Chan is to nominate a Mentor for the approval of the Board within 2 months of the date of the Tribunal's decision;

f. Mr Chan must bear the costs incurred to comply with these conditions;

g. Mr Chan must not be the preceptor of any intern pharmacist during the operational period of the suspended suspension.

3. The review period of the conditions imposed on the Mr Chan's registration is 12 months from the date of the Tribunal's decision.

4. Mr Chan not be permitted to apply for reinstatement of his unrestricted endorsement to deal with PSE until he has complied with conditions (a) and (d).

5. Mr Chan pay the Board's costs of and incidental to these proceedings fixed in the sum of $12,000.

6. Until further order of the Tribunal the publication of any information identifying the persons referred to in the decision as KN, KL, BD and LB is prohibited.